Radiology Question for the Week of April 4, 2016

Question:

Did CMS ever make a final decision to cover a NaF-18 PET scan to identify bone metastasis of cancer?

Answer:

Yes, the Centers for Medicare & Medicaid Services (CMS) issued the final decision on December 15, 2015. It stated that it will not cover the use of a NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer because it is not reasonable and necessary to diagnose or treat an illness or injury or to improve the functioning of a malformed body member.

CMS states that it will continue the requirement for coverage with evidence development (CED) for the next two years to allow confirmatory analyses to be performed and resulting evidence to be published to definitely answer whether the addition of NaF-18 PET imaging leads to a change in patient management to more appropriate palliative or curative care, or improved quality of life or survival.

Disclaimer: Every reasonable effort was made to ensure the accuracy of this information at the time it was published. However, due to the nature of industry changes over time we cannot guarantee its validity after the year it was published.